National Cancer Institute; Amended Notice of Meeting, 11236 [2017-03274]
Download as PDF
<![CDATA[
11236
Federal Register / Vol. 82, No. 33 / Tuesday, February 21, 2017 / Notices
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
sradovich on DSK3GMQ082PROD with NOTICES
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; NICHD T35
Teleconference Review.
Date: March 10, 2017.
Time: 1:30 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6710B
Rockledge Drive, Bethesda, MD 20817
(Telephone Conference Call).
Contact Person: Sherry L. Dupere, Ph.D.,
Chief, Scientific Review Branch, Scientific
Review Branch, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, National
Institutes of Health, 6710B Rockledge Drive,
Bethesda, MD 20817, 301–451–3415,
duperes@mail.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Learning Disabilities
Center.
Date: April 20–21, 2017.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Beacon Hotel and Corporate
Quarters, 1615 Rhode Island Avenue NW.,
Washington, DC 20036.
Contact Person: Marita R. Hopmann, Ph.D.,
Scientific Review Officer, Division of
Scientific Review, National Institute of Child
Health and Human Development, National
Institutes of Health, 6710B Rockledge Drive,
Bethesda, MD 20817, (301) 435–6911,
hopmannm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: February 14, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–03277 Filed 2–17–17; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
17:15 Feb 17, 2017
Jkt 241001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications/
contract proposals and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications/
contract proposals, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Provocative Question 2.
Date: March 15, 2017.
Time: 11:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W032, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Jun Fang, Ph.D., Scientific
Review Officer, Research Technology and
Contract Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W246, Bethesda, MD 20892–9750,
240–276–5460, jfang@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Provocative Question 4.
Date: March 16, 2017.
Time: 12:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W556, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Bratin K. Saha, Ph.D.,
Scientific Review Officer, Program
Coordination and Referral Branch, Division
of Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W556, Bethesda, MD 20892–9750,
240–276–6411, sahab@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cell and
Animal Models for Researching Disparities.
Date: March 21, 2017.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W554, Rockville, MD 20850 (Telephone
Conference Call).
PO 00000
Frm 00066
Fmt 4703
Sfmt 9990
Contact Person: Christopher L. Hatch,
Ph.D., Chief, Program Coordination and
Referral Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W554,
Rockville, MD 20892–9750, 240–276–6454,
ch29v@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: February 14, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–03282 Filed 2–17–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the President’s Cancer
Panel, March 27, 2017, 9:00 a.m. to
March 28, 2017, 1:00 p.m., Kimpton
Hotel Palomar, Philadelphia, PA 19103
which was published in the Federal
Register on February 1, 2017, 82 FR
8944.
This meeting notice is amended to
change the ending date and time from
March 28, 2017 at 1:00 p.m. to March
27, 2017 at 4:30 p.m. The agenda has
also been amended as follows:
‘‘Welcome and Introductions; Session 1:
The Pricing and Payment Landscapes—
Framing the Issues—1 and 2; Session 2:
Cancer Drug Value/Intervention
Framework; Public Comment; Session 3:
High-Cost/High Value Drugs; Session 4:
High-Cost/Modest Value Drugs; Public
Comment; Wrap-Up and Next Steps.’’
The meeting is open to the public.
Dated: February 14, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–03274 Filed 2–17–17; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\21FEN1.SGM
21FEN1
]]>Agencies
[Federal Register Volume 82, Number 33 (Tuesday, February 21, 2017)]
[Notices]
[Page 11236]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-03274]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the
President's Cancer Panel, March 27, 2017, 9:00 a.m. to March 28, 2017,
1:00 p.m., Kimpton Hotel Palomar, Philadelphia, PA 19103 which was
published in the Federal Register on February 1, 2017, 82 FR 8944.
This meeting notice is amended to change the ending date and time
from March 28, 2017 at 1:00 p.m. to March 27, 2017 at 4:30 p.m. The
agenda has also been amended as follows: ``Welcome and Introductions;
Session 1: The Pricing and Payment Landscapes--Framing the Issues--1
and 2; Session 2: Cancer Drug Value/Intervention Framework; Public
Comment; Session 3: High-Cost/High Value Drugs; Session 4: High-Cost/
Modest Value Drugs; Public Comment; Wrap-Up and Next Steps.'' The
meeting is open to the public.
Dated: February 14, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-03274 Filed 2-17-17; 8:45 am]
BILLING CODE 4140-01-P
